VKH
IMDZ

Virtu KCG Holdings’s Immune Design Corp. IMDZ Stock Holding History

Virtu KCG Holdings’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$153K Buy
+15,706
New +$110K ﹤0.01% 2284

Other funds holding IMDZ

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Virtu KCG Holdings's IMDZ Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Immune Design Corp. (IMDZ) in Q2 2017: 15,706 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #2284 among its holdings.

61 funds tracked by Wall St. Rank hold IMDZ as of Q2 2017.

  • Virtu KCG Holdings held 15,706 shares of Immune Design Corp. worth $153K as of Q2 2017.
  • Immune Design Corp. was a new Virtu KCG Holdings position in Q2 2017.
  • Immune Design Corp. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2284 holding.
  • 61 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.